本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bicara Therapeutics

23.20
+0.39001.71%
盤後23.200.00000.00%19:30 EDT
成交量:42.63萬
成交額:992.12萬
市值:15.35億
市盈率:-7.46
高:23.62
開:22.88
低:22.51
收:22.81
52周最高:30.99
52周最低:10.30
股本:6,617.29萬
流通股本:3,676.23萬
量比:0.80
換手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-3.1097
每股收益(LYR):-2.5230
淨資產收益率:-41.01%
總資產收益率:-26.14%
市淨率:3.27
市盈率(LYR):-9.20

資料載入中...

2026/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/02/19

重要事件披露

Form 8-K - Current report
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities